Early results indicate that Decoy20 causes expected, transient immune-related side effects and demonstrates preliminary efficacy with stable disease observed in patients post-treatment. The trial continues to assess safety, tolerability, and immune activation, supporting the hypothesis of beneficial transient immune stimulation by Decoy20.
Not PCa related: bacteria based immun... - Advanced Prostate...
Not PCa related: bacteria based immune therapy
Written by
Maxone73
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
PCa/Treatments and Immune System
(up to 4 weeks). Could this be a weakening of my immune system due to PCa and/or the medications I...
Current status of immune therapy
What is the status of immune therapy for treatment of prostate caner? Several years ago it was...
Anti PD1 immune therapy
anti PD1 immune therapy? How were the side effects, especially cases where unleashed immune system...
Oncolytic Virus Therapy for Pca
cells but also triggers an immune response to kill cancer cells. Side effects are said to minimal....
Shifting the Paradigm of Testosterone Replacement Therapy in PCa.
cancer or are on active surveillance, some providers see a role for TRT in these patients despite...
Options for Recurrent PCa w/ RT Initial Therapy
ADT + Taxane Based Therapy for Newly Diagnosed mHSPCa
Correct Therapy for High Risk PCa (Gleason 9)
Another short article on benefits of local therapy for advanced PCa
Current PCa treatment options in the UK do NOT include Triplet Therapy!
